Luminex

Luminex Corporation was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex® (NASDAQ: LMNX) develops, manufactures and markets innovative biological testing technologies with applications throughout the life-sciences industry. The company’s open-architecture xMAP® technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately.
Systems using xMAP technology (formerly known as LabMAP®) perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer. Using lasers and high-speed digital-signal processors, the analyzer simultaneously identifies the bioassay and measures the results, all in real time.
Reviews
Stewart Han
‘Membership Status’ indicates whether this member is an active reviewer on the site, and how many reviews have been published.| Status: | No. Reviews Published: |
| Member | 0 |
Reviewer![]() | 1-4 |
Advanced Reviewer![]() | 5-14 |
Expert Reviewer![]() ![]() | 15+ |
To be seen as an authority on SelectScience, find your products to review today., One Lambda
Claudia Queiroz
‘Membership Status’ indicates whether this member is an active reviewer on the site, and how many reviews have been published.| Status: | No. Reviews Published: |
| Member | 0 |
Reviewer![]() | 1-4 |
Advanced Reviewer![]() | 5-14 |
Expert Reviewer![]() ![]() | 15+ |
To be seen as an authority on SelectScience, find your products to review today., UTHSCSA
eyal ozeri
‘Membership Status’ indicates whether this member is an active reviewer on the site, and how many reviews have been published.| Status: | No. Reviews Published: |
| Member | 0 |
Reviewer![]() | 1-4 |
Advanced Reviewer![]() | 5-14 |
Expert Reviewer![]() ![]() | 15+ |
To be seen as an authority on SelectScience, find your products to review today., Ben-Gurion University of the Negev, Department of Clinical Biochemistry,
Latest news
News
Luminex® xMAP® Technology Featured in Several New Publications
10 May 2013
-
Luminex Corporation Receives U.S. FDA Clearance for MAGPIX® Instrument with Novel xTAG® Gastrointestinal Pathogen Panel
18 Apr 2013
-
Merck and Luminex Corporation Collaborate to Develop Companion Diagnostic Device to Support Investigational BACE inhibitor Clinical Development Program for Alzheimer’s Disease
28 Mar 2013
-
Luminex Receives FDA Clearance for First Comprehensive Gastrointestinal Pathogen Infectious Disease Diagnostic in the United States
18 Jan 2013
-
Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
07 Aug 2012




